慢性乙型肝炎的抗病毒治疗
摘要
慢性乙型病毒性肝炎(CHB)一直是一个全球生健康问题,全球大约3.5亿人感染乙肝病毒(HBV)[1].
出处
《全科医学临床与教育》
2003年第3期38-41,共4页
Clinical Education of General Practice
参考文献20
-
1[1]Lok AS,Heathcote EJ.HoofnagleJH. Management of hepatitis B 2000 summary of a workshop[ J ]. Gastroenterology, 2001, 120: 1825- 1853.
-
2[2]Kuhns M, McNamara A. Campbell C.Perrillo R.antigen[J]. Gastroenterology 1992, 103: 1649 ～ 56.
-
3[3]Lok AS .Chronic hepatitis B [J] .N Engl J Med 2002,346:1682- 1683.
-
4[4]Chevillotte G,Durbec JP,Gerolami A, et al. Interaction between hepatitis B virus and alcohol consumption in liver cirrhosis[J]. An epidemiologic study. Gastroenterology 1983,85: 141 - 145.
-
5汤钰菁,陈国良,郑瑞丹.拉米夫定与α-1b干扰素联合治疗慢性乙型肝炎[J].中华肝脏病杂志,2002,10(2):89-89. 被引量：16
-
6[6]Lok AS, Chyng HT,Liu VWS,et al.Long-term follow upof chronic hepatitis B patients treated with interferon alfa. Gastroenterology, 1993,105:1833 - 1838.
-
7[7]Cohard M,Poynard T,Mathurin P,Zarski JP.Prednisone - in terferon combination in the treatment of chronic hepatitis B: direct and indirect metaanalysis[J]. Hepatology, 1994,20: 1380- 1388.
-
8[8]Cooksley WG, Piraticsuth T, Wang YJ,et al. Forty- kda peginterferon alfa - 2a (pegasys: efficacy and safety results fvon a phase Ⅱ.randomised. actively controlled. Multicenter study in the treatment of HbeAg positive chronic hepatitis B (abstract) [J]. Hepatology, 2001,34: 349.
-
9[9]Lampertico P,Del Ninno E, Manzin A, et al.A randomized controlled trial of a 24 - month course of interferon alfa 2b in patient with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum[J]. Hepatology 1997,26:1621 - 1625.
-
10[10]Papatheodoridis GV, Mknesis E, Hzdziyannis SJ. The longterm outcome of interferon - alpha treated and untreated pa tients with HbeAg - negative chronic hepatitis B [J]. J Hepatol, 2001,34:306 - 313.
共引文献27
-
1徐兵,江家骥.拉米夫定抗病毒作用和机体免疫功能的相互影响[J].中西医结合肝病杂志,2001,11(S1):133-135. 被引量：1
-
2傅遵家,万喜英.α-2b干扰素与拉米夫定短期联合治疗慢性乙型肝炎34例疗效观察[J].九江医学,2008,23(1):25-26. 被引量：2
-
3陈治水,李春雷,王孔俊.拉米夫定加乙肝康治疗慢性乙型肝炎疗效观察[J].中国中西医结合消化杂志,2004,12(5):286-288. 被引量：2
-
4陈啟红.α-1b干扰素联合苦参碱治疗慢性乙型病毒性肝炎临床疗效观察[J].国际医药卫生导报,2005,11(4):72-74. 被引量：1
-
5冯燕,徐利华.拉米夫定治疗慢性乙型肝炎的常见问题[J].临床药物治疗杂志,2006,4(5):38-39. 被引量：4
-
6翟晓勇,孙惠敏.拉米夫定联合干扰素α-2b治疗慢性乙型肝炎疗效观察[J].实用肝脏病杂志,2007,10(1):30-32. 被引量：13
-
7赵连红,李俊萍,王蕾,董骏铭.260例慢性乙型肝炎住院患者药物治疗分析[J].天津药学,2007,19(2):34-36.
-
8谢媛琪,林小田,施华芳,陈颖虹.派罗欣治疗慢性乙型病毒性肝炎的观察与护理[J].护理学杂志,2007,22(9):72-73. 被引量：3
-
9邹鲁,杨菊梅.拉米夫定减量停药联合干扰素治疗慢性乙型肝炎的临床观察[J].江西医药,2008,43(1):30-32.
-
10何源浩,刘启华,吕军影.拉米夫定联合其他药物治疗慢性乙型肝炎近况[J].内科,2008,3(4):566-568.
-
1翁艳君,赵豫梅,宋滇平.降糖药物与肿瘤关系的研究进展[J].中华临床医师杂志（电子版）,2015,9(13):121-125.
-
2宁美英,赵静.关注老年糖尿病[J].中国社区医师（医学专业）,2011,13(34):10-11.
-
3梁泽容,杨刚毅,李伶.抵抗素和胰岛素抵抗的相关性研究进展[J].医学综述,2003,9(11):641-643.
